Netrin-1 acts as a survival factor for aggressive Neuroblastoma

Journal of Experimental Medicine

Volumn 206, Issue 4, 2009, Pages 833-847

  Delloye Bourgeois, Céline ^a   Fitamant, Julien ^a   Paradisi, Andrea ^a   Cappellen, David ^b   Douc Rasy, Setha ^b   Raquin, Marie Anne ^c   Stupack, Dwayne ^d   Nakagawara, Akira ^e   Rousseau, Raphaël ^a   Combaret, Valérie ^a   Puisieux, Alain ^a   Valteau Couanet, Dominique ^c   Bénard, Jean ^b   Bernet, Agnès ^a   Mehlen, Patrick ^a  

^a UNIVERSITÉ DE LYON   (France)

^b UMR 8126   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e CHIBA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NETRIN 1; NERVE GROWTH FACTOR; NETRIN-1; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BRAIN METASTASIS; CANCER GROWTH; CANCER SURVIVAL; CELL DEATH; CELL SURVIVAL; DISEASE FREE SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; CANCER STAGING; GENE EXPRESSION REGULATION; GENETICS; INFANT; MORTALITY; NEWBORN; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVOR; TUMOR CELL LINE; UPREGULATION;

CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DISEASE-FREE SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; INFANT, NEWBORN; NEOPLASM STAGING; NERVE GROWTH FACTORS; NEUROBLASTOMA; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SURVIVORS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 65549164340     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20082299     Document Type: Article

References (56)

1. Mehlen, P., S. Rabizadeh, S.J. Snipas, N. Assa-Munt, G. S. Salvesen, and D.E. Bredesen. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature. 1998 395801-804[CrossRef] [Medline]
2. Llambi, F., F. Causeret, E. Bloch-Gallego, and P. Mehlen. Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J. 2001 202715-2722[CrossRef][Medline]
3. Thibert, C., M.A. Teillet, F. Lapointe, L. Mazelin, N.M. Le Douarin, and P. Mehlen. Inhibition of neuroepithelial patched-induced apoptosis by sonic hedgehog. Science. 2003 301843-846 [Abstract/Free Full Text]
4. Stupack, D.G., X.S. Puente, S. Boutsaboualoy, C.M. Storgard, and D.A. Cheresh. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 2001 155459-470 [Abstract/Free Full Text]
5. Matsunaga, E., S. Tauszig-Delamasure, P.P. Monnier, B.K. Mueller, S.M. Strittmatter, P. Mehlen, and A. Chedotal. RGM and its receptor neogenin regulate neuronal survival. Nat. Cell Biol. 2004 6749-755[CrossRef][Medline]
6. Rabizadeh, S., J. Oh, L.T. Zhong, J. Yang, C.M. Bitler, L.L. Butcher, and D.E. Bredesen. Induction of apoptosis by the low-affinity NGF receptor. Science. 1993 261345-348[Abstract/Free Full Text]
7. Bordeaux, M.C., C. Forcet, L. Granger, V. Corset, C. Bidaud, M. Billaud, D.E. Bredesen, P. Edery, and P. Mehlen. The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J. 2000 194056-4063[CrossRef][Medline]
8. Mourali, J., A. Benard, F.C. Lourenco, C. Monnet, C. Greenland, C. Moog-Lutz, C. Racaud-Sultan, D. Gonzalez-Dunia, M. Vigny, P. Mehlen, et al. Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage. Mol. Cell. Biol. 2006 266209-6222[Abstract/Free Full Text]
9. Tauszig-Delamasure, S., L.Y. Yu, J.R. Cabrera, J. Bouzas-Rodriguez, C. Mermet-Bouvier, C. Guix, M.C. Bordeaux, U. Arumae, and P. Mehlen. The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigm. Proc. Natl. Acad. Sci. USA. 2007 10413361-13366[Abstract/Free Full Text]
10. Del Rio, G., D.J. Kane, K.D. Ball, and D.E. Bredesen. A novel motif identified in dependence receptors. PLoS One. 2007 2e463[CrossRef] [Medline]
11. Mehlen, P., and C. Thibert. Dependence receptors: between life and death. Cell. Mol. Life Sci. 2004 611854-1866[Medline]
12. Bredesen, D.E., P. Mehlen, and S. Rabizadeh. Receptors that mediate cellular dependence. Cell Death Differ. 2005 121031-1043[CrossRef] [Medline]
13. Serafini, T., S.A. Colamarino, E.D. Leonardo, H. Wang, R. Beddington, W.C. Skarnes, and M. Tessier-Lavigne. Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system. Cell. 1996 871001-1014[CrossRef][Medline]
14. Keino-Masu, K., M. Masu, L. Hinck, E.D. Leonardo, S.S. Chan, J.G. Culotti, and M. Tessier-Lavigne. Deleted in colorectal cancer (DCC) encodes a netrin receptor. Cell. 1996 87175-185 [CrossRef][Medline]
15. Forcet, C., E. Stein, L. Pays, V. Corset, F. Llambi, M. Tessier-Lavigne, and P. Mehlen. Netrin-1- mediated axon outgrowth requires deleted in colorectal cancer-dependent MAPK activation. Nature. 2002 417443-447[CrossRef] [Medline]
16. Ackerman, S.L., L.P. Kozak, S.A. Przyborski, L.A. Rund, B.B. Boyer, and B.B. Knowles. The mouse rostral cerebellar malformation gene encodes an UNC-5-like protein. Nature. 1997 386838-842[CrossRef][Medline]
17. Hong, K., L. Hinck, M. Nishiyama, M.M. Poo, M. Tessier-Lavigne, and E. Stein. A ligand-gated association between cytoplasmic domains of UNC5 and DCC family receptors converts netrin- induced growth cone attraction to repulsion. Cell. 1999 97927-941[CrossRef][Medline]
18. Mehlen, P., and A. Puisieux. Metastasis: a question of life or death. Nat. Rev. Cancer. 2006 6449-458[CrossRef][Medline]
19. Grady, W.M.. Making the case for DCC and UNC5C as tumor-suppressor genes in the colon. Gastroenterology. 2007 1332045-2049[CrossRef][Medline]
20. Mazelin, L., A. Bernet, C. Bonod-Bidaud, L. Pays, S. Arnaud, C. Gespach, D.E. Bredesen, J.Y. Scoazec, and P. Mehlen. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature. 2004 43180-84[CrossRef] [Medline]
21. Bernet, A., L. Mazelin, M.M. Coissieux, N. Gadot, S.L. Ackerman, J.Y. Scoazec, and P. Mehlen. Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies. Gastroenterology. 2007 1331840-1848[CrossRef][Medline]
22. Fearon, E.R., K.R. Cho, J.M. Nigro, S.E. Kern, J.W. Simons, J.M. Ruppert, S.R. Hamilton, A.C. Preisinger, G. Thomas, K.W. Kinzler, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 1990 24749-56[Abstract/Free Full Text]
23. Kinzler, K.W., and B. Vogelstein. Lessons from hereditary colorectal cancer. Cell. 1996 87159-170[CrossRef][Medline]
24. Thiebault, K., L. Mazelin, L. Pays, F. Llambi, M.O. Joly, J.C. Saurin, J.Y. Scoazec, G. Romeo, and P. Mehlen. The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment. Proc. Natl. Acad. Sci. USA. 2003 1004173-4178[Abstract/Free Full Text]
25. Shin, S.K., T. Nagasaka, B.H. Jung, N. Matsubara, W.H. Kim, J.M. Carethers, C.R. Boland, and A. Goel. Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer. Gastroenterology. 2007 1331849-1857[CrossRef][Medline]
26. Evans, A.E., G.J. D'Angio, and J. Randolph. A proposed staging for children with neuroblastoma. Children's cancer study group A. Cancer. 1971 27374-378[CrossRef][Medline]
27. Matthay, K.K., J.G. Villablanca, R.C. Seeger, D.O. Stram, R.E. Harris, N.K. Ramsay, P. Swift, H. Shimada, C.T. Black, G.M. Brodeur, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cisretinoic acid. Children's Cancer Group. N. Engl. J. Med. 1999 3411165-1173[Abstract/Free Full Text]
28. Valteau-Couanet, D., J. Michon, A. Boneu, C. Rodary, Y. Perel, C. Bergeron, H. Rubie, C. Coze, D. Plantaz, F. Bernard, et al. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol. J. Clin. Oncol. 2005 23532-540[Abstract/Free Full Text]
29. Reale, M.A., M. Reyes-Mugica, W.E. Pierceall, M.C. Rubinstein, L. Hedrick, S.L. Cohn, A. Nakagawara, G.M. Brodeur, and E.R. Fearon. Loss of DCC expression in neuroblastoma is associated with disease dissemination. Clin. Cancer Res. 1996 21097-1102[Abstract]
30. Krause, A., V. Combaret, I. Iacono, B. Lacroix, C. Compagnon, C. Bergeron, S. Valsesia-Wittmann, P. Leissner, B. Mougin, and A. Puisieux. Genome-wide analysis of gene expression in neuroblastomas detected by mass screening. Cancer Lett. 2005 225111-120[CrossRef][Medline]
31. Furne, C., N. Rama, V. Corset, A. Chedotal, and P. Mehlen. Netrin-1 is a survival factor during commissural neuron navigation. Proc. Natl. Acad. Sci. USA. 2008 10514465-14470[Abstract/Free Full Text]
32. Paradisi, A., C. Maisse, A. Bernet, M. Coissieux, M. Maccarrone, J. Scoazec, and P. Mehlen. NFB regulates netrin-1 expression and affects the conditional tumor suppressive activity of the netrin-1 receptors. Gastroenterology. 2008 1351248-1257[CrossRef][Medline]
33. Fitamant, J., C. Guenebeaud, M.M. Coissieux, C. Guix, I. Treilleux, J.Y. Scoazec, T. Bachelot, A. Bernet, and P. Mehlen. Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer. Proc. Natl. Acad. Sci. USA. 2008 1054850-4855[Abstract/Free Full Text]
34. Reale, M.A., G. Hu, A.I. Zafar, R.H. Getzenberg, S.M. Levine, and E.R. Fearon. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res. 1994 544493-4501[Abstract/Free Full Text]
35. Meyerhardt, J.A., A.T. Look, S.H. Bigner, and E.R. Fearon. Identification and characterization of neogenin, a DCC-related gene. Oncogene. 1997 141129-1136[CrossRef][Medline]
36. Cole, S.J., D. Bradford, and H.M. Cooper. Neogenin: a multi-functional receptor regulating diverse developmental processes. Int. J. Biochem. Cell Biol. 2007 391569-1575[CrossRef] [Medline]
37. Rajagopalan, S., L. Deitinghoff, D. Davis, S. Conrad, T. Skutella, A. Chedotal, B.K. Mueller, and S.M. Strittmatter. Neogenin mediates the action of repulsive guidance molecule. Nat. Cell Biol. 2004 6756-762[CrossRef] [Medline]
38. Llambi, F., F.C. Lourenco, D. Gozuacik, C. Guix, L. Pays, G. Del Rio, A. Kimchi, and P. Mehlen. The dependence receptor UNC5H2 mediates apoptosis through DAP-kinase. EMBO J. 2005 241192-1201[CrossRef][Medline]
39. Ferrandis, E., J. Da Silva, G. Riou, and J. Benard. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse. Cancer Res. 1994 542256-2261[Abstract/Free Full Text]
40. Link, B.C., U. Reichelt, M. Schreiber, J.T. Kaifi, R. Wachowiak, D. Bogoevski, M. Bubenheim, G. Cataldegirmen, K.A. Gawad, R. Issa, et al. Prognostic implications of Netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas. Ann. Surg. Oncol. 2007 142591-2599[Abstract/Free Full Text]
41. Inbal, B., O. Cohen, S. Polak-Charcon, J. Kopolovic, E. Vadai, L. Eisenbach, and A. Kimchi. DAP kinase links the control of apoptosis to metastasis. Nature. 1997 390180-184[CrossRef] [Medline]
42. Stupack, D.G., T. Teitz, M.D. Potter, D. Mikolon, P.J. Houghton, V.J. Kidd, J.M. Lahti, and D.A. Cheresh. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature. 2006 43995-99 [CrossRef][Medline]
43. Yebra, M., A.M. Montgomery, G.R. Diaferia, T. Kaido, S. Silletti, B. Perez, M.L. Just, S. Hildbrand, R. Hurford, E. Florkiewicz, et al. Recognition of the neural chemoattractant Netrin-1 by integrins alpha6beta4 and alpha3beta1 regulates epithelial cell adhesion and migration. Dev. Cell. 2003 5695-707[CrossRef][Medline]
44. Park, K.W., D. Crouse, M. Lee, S.K. Karnik, L.K. Sorensen, K.J. Murphy, C.J. Kuo, and D.Y. Li. The axonal attractant Netrin-1 is an angiogenic factor. Proc. Natl. Acad. Sci. USA. 2004 10116210-16215[Abstract/Free Full Text]
45. Lu, X., F. Le Noble, L. Yuan, Q. Jiang, B. De Lafarge, D. Sugiyama, C. Breant, F. Claes, F. De Smet, J.L. Thomas, et al. The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature. 2004 432179-186[CrossRef][Medline]
46. Nguyen, A., and H. Cai. Netrin-1 induces angiogenesis via a DCC-dependent ERK1/2-eNOS feed-forward mechanism. Proc. Natl. Acad. Sci. USA. 2006 1036530-6535[Abstract/Free Full Text]
47. Wilson, B.D., M. Ii, K.W. Park, A. Suli, L.K. Sorensen, F. Larrieu-Lahargue, L.D. Urness, W. Suh, J. Asai, G.A. Kock, et al. Netrins promote developmental and therapeutic angiogenesis. Science. 2006 313640-644[Abstract/Free Full Text]
48. Jiang, Y., L. Min-tsai, and M.D. Gershon. Netrins and DCC in the guidance of migrating neural Crest-derived cells in the developing bowel and pancreas. Dev. Biol. 2003 258364-384[CrossRef] [Medline]
49. Roperch, J.P., K. El Ouadrani, A. Hendrix, S. Emami, O. De Wever, G. Melino, and C. Gespach. Netrin-1 induces apoptosis in human cervical tumor cells via the TAp73alpha tumor suppressor. Cancer Res. 2008 688231-8239[Abstract/Free Full Text]
50. Bourhis, J., C. Dominici, H. McDowell, G. Raschella, G. Wilson, M.A. Castello, E. Plouvier, J. Lemerle, G. Riou, J. Benard, et al. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma. J. Clin. Oncol. 1991 91371-1375[Abstract]
51. Rubie, H., D. Plantaz, C. Coze, J. Michon, D. Frappaz, M.C. Baranzelli, P. Chastagner, M.C. Peyroulet, and O. Hartmann. Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Societe Francaise d'Oncologie Pediatrique. Med. Pediatr. Oncol. 2001 36247-250[CrossRef][Medline]
52. Ambros, I.M., J. Benard, M. Boavida, N. Bown, H. Caron, V. Combaret, J. Couturier, C. Darnfors, O. Delattre, J. Freeman-Edward, et al. Quality assessment of genetic markers used for therapy stratification. J. Clin. Oncol. 2003 212077-2084[Abstract/Free Full Text]
53. Ghoumari, A.M., R. Wehrle, O. Bernard, C. Sotelo, and I. Dusart. Implication of Bcl-2 and Caspase-3 in age-related Purkinje cell death in murine organotypic culture: an in vitro model to study apoptosis. Eur. J. Neurosci. 2000 122935-2949[CrossRef][Medline]
54. Vandesompele, J., K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, and F. Speleman. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002 3research0034.1-0034.11[CrossRef]
55. Gotoh, T., H. Hosoi, T. Iehara, Y. Kuwahara, S. Osone, K. Tsuchiya, M. Ohira, A. Nakagawara, H. Kuroda, and T. Sugimoto. Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction. J. Clin. Oncol. 2005 235205-5210 [Abstract/Free Full Text]
56. Schneider, T., F. Osl, T. Friess, H. Stockinger, and W. Scheuer. Quantification of human Alu sequences by real-time PCR-an improved method to measure therapeutic efficacy of antimetastatic drugs in human xenotransplants. Clin. Exp. Metastasis. 2002 19571-582[CrossRef] [Medline]